Skip to content
Top Globe News – Lifestyle
Author:
Shattuck Labs, Inc.
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
June 5, 2026
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026